Pasithea Therapeutics Files Q1 2025 10-Q
Ticker: KTTAW · Form: 10-Q · Filed: May 15, 2025 · CIK: 1841330
Sentiment: neutral
Topics: 10-Q, quarterly-report, pharmaceuticals
TL;DR
Pasithea Therapeutics filed its Q1 2025 10-Q on May 15, 2025. Check financials.
AI Summary
Pasithea Therapeutics Corp. filed its 10-Q for the quarterly period ended March 31, 2025. The company, incorporated in Delaware with its principal executive offices in Miami Beach, Florida, operates in the Pharmaceutical Preparations industry. The filing was made on May 15, 2025, under SEC file number 001-40804.
Why It Matters
This filing provides investors with the latest financial performance and operational updates for Pasithea Therapeutics for the first quarter of 2025.
Risk Assessment
Risk Level: low — This is a standard quarterly filing and does not inherently present new risks.
Key Numbers
- 001-40804 — SEC File Number (Identifies the company's filings with the SEC.)
Key Players & Entities
- Pasithea Therapeutics Corp. (company) — Registrant
- March 31, 2025 (date) — Quarterly Period End Date
- May 15, 2025 (date) — Filing Date
- 001-40804 (other) — SEC File Number
- Miami Beach, Florida (location) — Principal Executive Offices
FAQ
What is the reporting period for this 10-Q filing?
The 10-Q filing is for the quarterly period ended March 31, 2025.
When was this 10-Q filed with the SEC?
This 10-Q was filed on May 15, 2025.
What is the company's principal executive office location?
The principal executive offices are located at 1111 Lincoln Road, Suite 500, Miami Beach, Florida.
What is the company's SIC code?
The Standard Industrial Classification (SIC) code is 2834, Pharmaceutical Preparations.
What is the company's state of incorporation?
Pasithea Therapeutics Corp. is incorporated in Delaware.
Filing Details
This Form 10-Q (Form 10-Q) was filed with the SEC on May 15, 2025 regarding Pasithea Therapeutics Corp. (KTTAW).